Evolution, revolution and heresy in the genetics of infectious disease susceptibility

Philosophical Transactions of the Royal Society B: Biological Sciences

Volumn 367, Issue 1590, 2012, Pages 840-849

  Hill, Adrian V S ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Diversity; Evolution; Exome; Genomics; Pathogen driven selection; Susceptibility

Indexed keywords

GENETICS; GENOMICS; HUMAN EVOLUTION; HUMAN IMMUNODEFICIENCY VIRUS; INFECTIOUS DISEASE; MORTALITY; NATURAL SELECTION; PATHOGEN;

BACTERIA (MICROORGANISMS);

EID: 84856654988     PISSN: 09628436     EISSN: 14712970     Source Type: Journal    
DOI: 10.1098/rstb.2011.0275     Document Type: Review

References (84)

1. Allison, A. C. 1954 Protection afforded by sickle-cell trait against subtertain malarial infection. Br. Med. J. 1, 290-294. (doi:10.1136/bmj.1.4857.290)
2. Huang, Y. et al. 1996 The role of a mutant CCR5 allele in HIV-1 transmission and disease progression. Nat. Med. 2, 1240-1243. (doi:10.1038/nm1196-1240)
3. Arevalo-Herrera, M. et al. 2005 Immunogenicity and protective efficacy of recombinant vaccine based on the receptor-binding domain of the Plasmodium vivax Duffy binding protein in Aotus monkeys. Am. J. Trop. Med. Hyg. 73, 25-31.
4. Miller, L. H., Mason, S. J., Clyde, D. F. & McGinniss, M. H. 1976 The resistance factor to Plasmodium vivax in blacks. The Duffy-blood-group genotype, FyFy. N. Engl. J. Med. 295, 302-304. (doi:10.1056/NEJM 197608052950602)
5. Petersen, K. A., Matthiesen, F., Agger, T., Kongerslev, L., Thiel, S., Cornelissen, K. & Axelsen, M. 2006 Phase I safety, tolerability, and pharmacokinetic study of recombinant human mannan-binding lectin. J. Clin. Immunol. 26, 465-475. (doi:10.1007/s10875-006-9037-z)
6. McClellan, J. & King, M. C. 2010 Genetic heterogeneity in human disease. Cell 141, 210-217. (doi:10.1016/j.cell. 2010.03.032)
7. Bousfiha, A. et al. 2010 Primary immunodeficiencies of protective immunity to primary infections. Clin. Immunol. 135, 204-209. (doi:10.1016/j.clim.2010.02.001)
8. Gedda, L. et al. 1984 Heredity and infectious diseases: a twin study. Acta Genet. Med. Gemellol (Roma) 33, 497-500.
9. Comstock, G. W. 1978 Tuberculosis in twins: a reanalysis of the Prophit survey. Am. Rev. Respir. Dis. 117, 621-624.
10. Chakravarti, M. R. & Vogel, F. 1973 A twin study on leprosy. Stuttgart, Germany: Thieme.
11. Malaty, H. M., Engstrand, L., Pedersen, N. L. & Graham, D. Y. 1994 Helicobacter pylori infection: genetic and environmental influences. A study of twins. Ann. Intern. Med. 120, 982-986.
12. Lin, T. M. et al. 1989 Hepatitis B virus markers in Chinese twins. Anticancer Res. 9, 737-741.
13. Newport, M. J., Goetghebuer, T., Weiss, H. A., The MRC Gambia Twin Study Group, Whittle, H., Siegrist, C.-A. & Marchant, A. 2004 Genetic regulation of immune responses to vaccines in early life. Genes Immun. 5, 122-129. (doi:10.1038/sj.gene.6364051)
14. Tan, P. L., Jacobson, R. M., Poland, G. A., Jacobsen, S. J. & Pankratz, V. S. 2001 Twin studies of immunogenicity-determining the genetic contribution to vaccine failure. Vaccine 19, 2434-2439. (doi:10.1016/S0264-410X(00)00468-0)
15. Fortin, A., Abel, L., Casanova, J. L. & Gros, P. 2007 Host genetics of mycobacterial diseases in mice and men: forward genetic studies of BCG-osis and tuberculosis. Annu. Rev. Genomics Hum. Genet. 8, 163-192. (doi:10. 1146/annurev.genom.8.080706.092315)
16. Tobin, D. M. et al. 2010 The lta4h locus modulates susceptibility tomycobacterial infection in zebrafish and humans. Cell 140, 717-730. (doi:10.1016/j.cell.2010.02.013)
17. Curtis, J. et al. 2011 Association analysis of the LTA4H gene polymorphisms and pulmonary tuberculosis in 9115 subjects. Tuberculosis (Edinb.) 91, 22-25. (doi:10. 1016/j.tube.2010.11.001)
18. Siddiqui, M. R. et al. 2001 A major susceptibility locus for leprosy in India maps to chromosome 10p13. Nat. Genet. 27, 439-441. (doi:10.1038/86958)
19. Mira, M. T. et al. 2004 Susceptibility to leprosy is associated with PARK2 and PACRG. Nature 427, 636-640. (doi:10.1038/nature02326)
20. Tosh, K., Meisner, S., Siddiqui, M. R., Balakrishnan, K., Ghei, S., Golding, M., Sengupta, U., Pitchappan, R. M. & Hill, A. V. K. 2002 A region of chromosome 20 is linked to leprosy susceptibility in a South Indian population. J. Infect. Dis. 186, 1190-1193. (doi:10.1086/343806)
21. Bellamy, R. et al. 2000 Genetic susceptibility to tuberculosis in Africans: a genome-wide scan. Proc. Natl Acad. Sci. USA 97, 8005-8009. (doi:10.1073/pnas. 140201897)
22. Cooke, G. S. et al. 2008 Mapping of a novel susceptibility locus suggests a role for MC3R and CTSZ in human tuberculosis. Am. J. Respir. Crit. Care Med. 178, 203-207. (doi:10.1164/rccm.200710-1554OC)
23. Frodsham, A. J. et al. 2006 Class II cytokine receptor gene cluster is a major locus for hepatitis B persistence. Proc. Natl Acad. Sci. USA 103, 9148-9153. (doi:10. 1073/pnas.0602800103)
24. Abel, L. & Demenais, F. 1988 Detection of major genes for susceptibility to leprosy and its subtypes in a Caribbean island: Desirade island. Am. J. Hum. Genet. 42, 256-266.
25. Abel, L., Cot, M., Mulder, L., Carnevale, P. & Feingold, J. 1992 Segregation analysis detects a major gene controlling blood infection levels in human malaria. Am. J. Hum. Genet. 50, 1308-1317.
26. Vogel, F. 1970 Controversy in human genetics. ABO blood groups and disease. Am. J. Hum. Genet. 22, 464-475.
27. Mourant, A. E. 1973 Associations between hereditary blood factors and diseases. Bull. World Health Organ. 49, 93-101.
28. Hill, A. V. 2006 Aspects of genetic susceptibility to human infectious diseases. Annu. Rev. Genet. 40, 469-486. (doi:10.1146/annurev.genet.40.110405.090546)
29. Palmer, M. S., Dryden, A. J., Hughes, J. T. & Collinge, J. 1991 Homozygous prion protein genotype predisposes to sporadic Creutzfeldt-Jakob disease. Nature 352, 340-342. (doi:10.1038/352340a0)
30. Genton, B., AI-Yaman, F., Mgone, C. S., Alexander, N., Paniu, M. M., Alpers, M. P. & Mokela, D. 1995 Ovalocytosis and cerebral malaria. Nature 378, 564-565. (doi:10.1038/378564a0)
31. Lindesmith, L., Moe, C., Marionneau, S., Ruvoen, N., Jiang, X., Lindblad, L., Stewart, P., LePendu, J. & Baric, R. 2003 Human susceptibility and resistance to Norwalk virus infection. Nat. Med. 9, 548-553. (doi:10.1038/nm860)
32. Zhang, F. R. et al. 2009 Genomewide association study of leprosy. N. Engl. J. Med. 361, 2609-2618. (doi:10. 1056/NEJMoa0903753)
33. Pereyra, F. et al. 2010 The major genetic determinants of HIV-1 control affect HLA class I peptide presentation. Science 330, 1551-1557. (doi:10.1126/science.1195271)
34. Mbarek, H. et al. 2011 A genome-wide association study of chronic hepatitis B identified novel risk locus in a Japanese population. Hum. Mol. Genet. 20, 3884-3892. (doi:10.1093/hmg/ddr301)
35. Fry, A. E. et al. 2008 Common variation in the ABO glycosyltransferase is associated with susceptibility to severe Plasmodium falciparum malaria. Hum. Mol. Genet. 17, 567-576. (doi:10.1093/hmg/ddm331)
36. Ruwende, C. et al. 1995 Natural selection of hemi-and heterozygotes for G6PD deficiency in Africa by resistance to severe malaria. Nature 376, 246-249. (doi:10. 1038/376246a0)
37. Davila, S. et al. 2010 Genome-wide association study identifies variants in the CFH region associated with host susceptibility to meningococcal disease. Nat. Genet. 42, 772-776. (doi:10.1038/ng.640)
38. Khor, C. C. et al. 2007 A Mal functional variant is associated with protection against invasive pneumococcal disease, bacteremia, malaria and tuberculosis. Nat. Genet. 39, 523-528. (doi:10.1038/ng1976)
39. Wong, S. H. et al. 2010 Leprosy and the adaptation of human toll-like receptor 1. PLoS Pathog. 6, e1000979. (doi:10.1371/journal.ppat.1000979)
40. Thomas, D. L. et al. 2009 Genetic variation in IL28B and spontaneous clearance of hepatitis C virus. Nature 461, U752-U798. (doi:10.1038/nature08463)
41. Roy, S. et al. 2002 MBL genotype and risk of invasive pneumococcal disease: a case-control study. Lancet 359, 1569-1573. (doi:10.1016/S0140-6736(02)08516-1)
42. Vannberg, F. O., Chapman, S. J. & Hill, A. V. 2011 Human genetic susceptibility to intracellular pathogens. Immunol. Rev. 240, 105-116. (doi:10.1111/j.1600-065X.2010.00996.x)
43. Kaslow, R. A., McNicholl, J. & Hill, A. V. S. 2008 Genetic susceptibility to infectious diseases. Oxford, UK: Oxford University Press.
44. O'Neill, L. A. & Bowie, A. G. 2010 Sensing and signaling in antiviral innate immunity. Curr. Biol. 20, R328-R333. (doi:10.1016/j.cub.2010.01.044)
45. Khor, C. C. et al. 2010 CISH and susceptibility to infectious diseases. N. Engl. J. Med. 362, 2092-2101. (doi:10. 1056/nejmoa0905606)
46. Johnson, C. M. et al. 2007 A common polymorphism impairs cell surface trafficking and functional responses of TLR1 but protects against leprosy. J. Immunol. 178, 7520-7524.
47. Ma, X., Liu, Y., Gowen, B. B., Graviss, E. A., Clark, A. G. & Musser, J. M. 2007 Full-exon resequencing reveals toll-like receptor variants contribute to human susceptibility to tuberculosis disease. PLoS ONE 2, e1318. (doi:10.1371/journal.pone.0001318)
48. Lee, Y. H., Rho, Y. H., Choi, S. J., Ji, J. D., Song, G. G., Nath, S. K. & Harley, J. B. 2006 The PTPN22 C1858T functional polymorphism and autoimmune diseases: a meta-analysis. Rheumatology (Oxford) 46, 49-56. (doi:10.1093/rheumatology/kel170)
49. Chapman, S. J. et al. 2006 PTPN22 and invasive bacterial disease. Nat. Genet. 38, 499-500. (doi:10.1038/ng0506-499)
50. Rani, R., Singh, A., Israni, N., Sharma, P. & Kar, H. K. 2009 The role of polymorphic protein tyrosine phosphatase non-receptor type 22 in leprosy. J. Invest. Dermatol. 129, 2726-2728. (doi:10.1038/jid.2009.140)
51. Chapman, S. J. et al. 2007 IkappaB genetic polymorphisms and invasive pneumococcal disease. Am. J. Respir. Crit. Care Med. 176, 181-187. (doi:10.1164/rccm. 200702-169OC)
52. Chapman, S. J. et al. 2010 NFKBIZ polymorphisms and susceptibility to pneumococcal disease in European and African populations. Genes Immun. 11, 319-325. (doi:10.1038/gene.2009.76)
53. Chapman, S. J. et al. 2010 Common NFKBIL2 polymorphisms and susceptibility to pneumococcal disease: a genetic association study. Crit. Care 14, R227. (doi:10.1186/cc9377)
54. Liu, L. et al. 2011 Gain-of-function human STAT1 mutations impair IL-17 immunity and underlie chronic mucocutaneous candidiasis. J. Exp. Med. 208, 1635-1648. (doi:10.1084/jem.20110958)
55. Wellcome Trust Case-Control Consortium. 2007 Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 447, 661-678. (doi:10.1038/nature05911)
56. Manolio, T. A. et al. 2009 Finding the missing heritability of complex diseases. Nature 461, 747-753. (doi:10. 1038/nature08494)
57. Thye, T. et al. 2010 Genome-wide association analyses identifies a susceptibility locus for tuberculosis on chromosome 18q11.2. Nat. Genet. 42, 739-741. (doi:10.1038/ng.639)
58. Jallow, M. et al. 2009 Genome-wide and fine-resolution association analysis of malaria in West Africa. Nat. Genet. 41, 657-665. (doi:10.1038/ng.388)
59. Troyer, J. L. et al. 2011 Genome-wide association study implicates PARD3B-based AIDS restriction. J. Infect. Dis. 203, 1491-1502. (doi:10.1093/infdis/jir046)
60. Thye, T. et al. In press. Common variants at 11p13 are associated with susceptibility to tuberculosis. Nat. Genet.
61. Wong, S. H., Hill, A. V. & Vannberg, F. O. 2010 Genomewide association study of leprosy. N. Engl. J. Med. 362, 1446-1447; author reply 1447-1448. (doi:10. 1056/nejmc1001451)
62. Behr, M. A. & Schurr, E. 2006 Mycobacteria in Crohn's disease: a persistent hypothesis. Inflamm. Bowel Dis. 12, 1000-1004. (doi:10.1097/01.mib.0000228183.70197.dd)
63. Fellay, J., Shianna, K. V., Telenti, A. & Goldstein, D. B. 2010 Host genetics and HIV-1: the final phase? PLoS Pathog. 6, e1001033. (doi:10.1371/journal.ppat.1001033)
64. Fellay, J. et al. 2009 Common genetic variation and the control of HIV-1 in humans. PLoS Genet. 5, e1000791. (doi:10.1371/journal.pgen.1000791)
65. Malaria Genomic Epidemiology Network. 2008 A global network for investigating the genomic epidemiology of malaria. Nature 456, 732-737. (doi:10.1038/nature07632)
66. Gorlov, I. P., Gorlova, O. Y., Frazier, M. L., Spitz, M. R. & Amos, C. I. 2011 Evolutionary evidence of the effect of rare variants on disease etiology. Clin. Genet. 79, 199-206. (doi:10.1111/j.1399-0004.2010.01535.x)
67. Casanova, J. L. & Abel, L. 2007 Primary immunodeficiencies: a field in its infancy. Science 317, 617-619. (doi:10.1126/science.1142963)
68. Alcais, A., Quintana-Murci, L., Thaler, D. S., Schurr, E., Abel, L. & Casanova, J.-L. 2010 Life-threatening infectious diseases of childhood: single-gene inborn errors of immunity? Ann. NY Acad. Sci. 1214, 18-33. (doi:10.1111/j.1749-6632.2010.05834.x)
69. Casanova, J. L. & Abel, L. 2005 Inborn errors of immunity to infection: the rule rather than the exception. J. Exp. Med. 202, 197-201. (doi:10.1084/jem.20050854)
70. Choi, M. et al. 2009 Genetic diagnosis by whole exome capture and massively parallel DNA sequencing. Proc. Natl Acad. Sci. USA 106, 19 096-19 101. (doi:10. 1073/pnas.0910672106)
71. Kim, D. W., Nam, S. H., Kim, R. N., Choi, S. H. & Park, H. S. 2010 Whole human exome capture for high-throughput sequencing. Genome 53, 568-574. (doi:10.1139/G10-025)
72. Teer, J. K. & Mullikin, J. C. 2010 Exome sequencing: the sweet spot before whole genomes. Hum. Mol. Genet. 19, R145-151. (doi:10.1093/hmg/ddq333)
73. Smirnova, I., Mann, N., Dols, A., Derkx, H. H., Hibberd, M. L., Levin, M. & Beutler, B. 2003 Assay of locus-specific genetic load implicates rare Toll-like receptor 4 mutations in meningococcal susceptibility. Proc. Natl Acad. Sci. USA 100, 6075-6080. (doi:10.1073/pnas.1031605100)
74. Grossman, S. R. et al. 2010 A composite of multiple signals distinguishes causal variants in regions of positive selection. Science 327, 883-886. (doi:10.1126/science. 1183863)
75. Fincham, J. R. 1972 Heterozygous advantage as a likely general basis for enzyme polymorphisms. Heredity 28, 387-391. (doi:10.1038/hdy.1972.49)
76. Hedrick, P. W. 1972 Maintenance of genetic variation with a frequency-dependent selection model as compared to the overdominant model. Genetics 72, 771-775.
77. Bodmer, W. F. 1975 Evolution of HL-A and other major histocompatibility systems. Genetics 79(Suppl.), 293-304.
78. Hill, A. V. S. 1991 HLA associations with malaria in Africa: some implications for MHC evolution. In Molecular evolution of the major histocompatibility complex (eds J. Klein & D. Klein), pp. 403-420. Berlin, Germany: Springer.
79. Sabeti, P. C. et al. 2007 Genome-wide detection and characterization of positive selection in human populations. Nature 449, 913-918. (doi:10.1038/nature06250)
80. Sanchez-Mazas, A. et al. 2011 Immunogenetics as a tool in anthropological studies. Immunology 133, 143-164. (doi:10.1111/j.1365-2567.2011.03438.x)
81. Hill, A. V. S. et al. 1985 Melanesians and Polynesians share a unique alpha-thalassemia mutation. Am. J. Hum. Genet. 37, 571-80.
82. de Vries, R. R., Fat, R. F., Nijenhuis, L. E. & van Rood, J. J. 1976 HLA-linked genetic control of host response to Mycobacterium leprae. Lancet 2, 1328-1330. (doi:10. 1016/S0140-6736(76)91975-9)
83. Monot, M. et al. 2009 Comparative genomic and phylogeographic analysis of Mycobacterium leprae. Nat. Genet. 41, 1282-1289. (doi:10.1038/ng.477)
84. Caws, M. et al. 2008 The influence of host and bacterial genotype on the development of disseminated disease with Mycobacterium tuberculosis. PLoS Pathog. 4, e1000034. (doi:10.1371/journal.ppat.1000034)